[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX345695B - Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel. - Google Patents

Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel.

Info

Publication number
MX345695B
MX345695B MX2014003449A MX2014003449A MX345695B MX 345695 B MX345695 B MX 345695B MX 2014003449 A MX2014003449 A MX 2014003449A MX 2014003449 A MX2014003449 A MX 2014003449A MX 345695 B MX345695 B MX 345695B
Authority
MX
Mexico
Prior art keywords
heterocyclocarbonylaminothiazoles
cosmetic
combat
skin
dermatological preparations
Prior art date
Application number
MX2014003449A
Other languages
English (en)
Other versions
MX2014003449A (es
Inventor
Kolbe Ludger
Scherner Cathrin
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Publication of MX2014003449A publication Critical patent/MX2014003449A/es
Publication of MX345695B publication Critical patent/MX345695B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Heterociclocarbonilaminotiazoles de fórmula general (I) en la que R1 significa -morfolino, -piperidin-1-ilo, -piperazin-1-ilo, - ( (4-alquil) -piperazin-1-ilo), - pirrolidinilo, -(1H-pirrol-1-ilo), -azetidin-1-ilo, -azepan-1-ilo, -2,3,4,5-tetrahidro-1-H-azepin-1-ilo, -2,3-dihidro-1H-azepin-1-ilo , -1H-azepin-1-ilo, -tetrahidro-2H-piran-4-ilo, -4H-piran-4-ilo, -2H-piran-4-ilo, -oxepanilo, -dioxanilo, -tetrahidrofuranilo, -pirrazolilo, así como preparaciones cosméticas o dermatológicas con un contenido eficaz en uno o varios heteroalquilamidotiazoles así como su uso para el tratamiento y/o la profilaxis cosméticos o dermatológicos de pigmentación de la piel indeseada.
MX2014003449A 2011-09-23 2012-09-18 Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel. MX345695B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102011083283A DE102011083283A1 (de) 2011-09-23 2011-09-23 Heteroalkylamidothiazole, deren kosmetische oder dermatologische Verwendung sowie kosmetische oder dermatologische Zubereitungen mit einem Gehalt an solchen Heteroalkylamidothiazolen
PCT/EP2012/068376 WO2013041537A1 (de) 2011-09-23 2012-09-18 Heterocyclocarbonylaminothiazole, sie enthaltende kosmetische oder dermatologische zubereitungen und deren verwendung zur bekämpfung prophylaxe unerwünschter pigmentierung der haut

Publications (2)

Publication Number Publication Date
MX2014003449A MX2014003449A (es) 2015-03-09
MX345695B true MX345695B (es) 2017-02-10

Family

ID=46889038

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014003449A MX345695B (es) 2011-09-23 2012-09-18 Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel.

Country Status (8)

Country Link
EP (1) EP2758382B1 (es)
JP (1) JP6045593B2 (es)
CN (1) CN103889965B (es)
DE (1) DE102011083283A1 (es)
ES (1) ES2610252T3 (es)
MX (1) MX345695B (es)
PL (1) PL2758382T3 (es)
WO (1) WO2013041537A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102013204081A1 (de) 2013-03-11 2014-09-11 Beiersdorf Ag Wirkstoffkombinationen aus Alkylamidothiazolen und einen oder mehreren kosmetisch oder dermatologisch unbedenklichen Konservierungsmitteln
DE102013208880A1 (de) * 2013-05-14 2014-11-20 Beiersdorf Ag Stabilisierte Zubereitungen mit einem Gehalt an Ascorbinsäure und Gemischen aus Natriumstearoylglutamat und/oder Cetylstearylsulfat in Kombination mit Glycerylstearat
DE102013213170A1 (de) 2013-07-04 2015-01-08 Beiersdorf Ag Octocrylenfreies, geruchsstabiles Sonnenschutzmittel
DE102013226711A1 (de) * 2013-12-19 2015-06-25 Beiersdorf Ag Verwendung von Alkylamidothiazolen in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe vor und Behandlung von sensibler Haut
WO2019021030A1 (en) * 2017-07-26 2019-01-31 Clr Chemisches Laboratorium Dr. Kurt Richter Gmbh TOPICAL COMPOSITIONS BASED ON PLANTS
CN108929271B (zh) * 2018-06-29 2021-08-31 中国药科大学 酪氨酸酶抑制剂及其制备方法与用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217355A (en) * 1978-04-24 1980-08-12 Pfizer Inc. Amide therapeutic agents
WO1993000342A1 (en) * 1991-06-21 1993-01-07 Boehringer Mannheim Italia S.P.A. 2-amino-4-aryl-thiazoles with antiasthmatic and anti-inflammatory activities on the respiratory tract
GB0028383D0 (en) * 2000-11-21 2001-01-03 Novartis Ag Organic compounds
US7265134B2 (en) * 2001-08-17 2007-09-04 Merck & Co., Inc. Tyrosine kinase inhibitors
US7504410B2 (en) 2002-11-28 2009-03-17 Schering Aktiengesellschaft Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
CA2532313A1 (en) * 2003-07-16 2005-01-27 Institute Of Medicinal Molecular Design. Inc. Medicament for treatment of dermal pigmentation
EP1664006A2 (en) * 2003-09-06 2006-06-07 Vertex Pharmaceuticals Incorporated Modulators of atp-binding cassette transporters
CN101014597A (zh) * 2004-04-02 2007-08-08 沃泰克斯药物股份有限公司 可用作rock和其他蛋白激酶抑制剂的吖吲哚
SE0401970D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Novel compounds
JP2009503107A (ja) * 2005-08-04 2009-01-29 アポジー・バイオテクノロジー・コーポレイション スフィンゴシンキナーゼ阻害剤およびそれらの使用方法
US20070238746A1 (en) 2006-04-06 2007-10-11 Trixi Brandl Thiazolyl-dihydro-chinazoline
ATE481409T1 (de) * 2006-05-18 2010-10-15 Hoffmann La Roche Thiazolopyramidin/pyridinharnstoffderivate als antagonisten am adenosin-a2b-rezeptor
JP4613248B2 (ja) 2008-02-08 2011-01-12 株式会社資生堂 美白剤及び皮膚外用剤
DE102010012594A1 (de) * 2010-03-23 2011-09-29 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an einem oder mehreren Thiazolderivaten

Also Published As

Publication number Publication date
DE102011083283A1 (de) 2013-03-28
MX2014003449A (es) 2015-03-09
WO2013041537A1 (de) 2013-03-28
CN103889965A (zh) 2014-06-25
PL2758382T3 (pl) 2017-03-31
EP2758382A1 (de) 2014-07-30
EP2758382B1 (de) 2016-11-09
JP2014526537A (ja) 2014-10-06
JP6045593B2 (ja) 2016-12-14
CN103889965B (zh) 2016-02-10
ES2610252T3 (es) 2017-04-26

Similar Documents

Publication Publication Date Title
PH12016502132A1 (en) Aryl-or heteroaryl-substituted benzene compounds
ZA201701460B (en) Gamma-diketones for treatment and prevention of aging skin and wrinkles
MX2020010535A (es) Inhibidor de ezh2 para usarse en el tratamiento de sarcoma epiteloide.
MX339201B (es) Compuestos de sulfonamida y métodos para elaborarlos y usarlos.
PH12015500825A1 (en) Substituted benzene compounds
MX2013011922A (es) Compuestos de benceno substituido.
EA019744B9 (ru) Изотиазолилоксифениламидины и их применение для борьбы с фитопатогенными грибами и семенной материал, обработанный изотиазолилоксифениламидинами
MY181928A (en) Sodium channel modulators for the treatment of pain and diabetes
WO2012076109A3 (de) 2-pyrone
MX345695B (es) Heterociclocarbonilaminotiazoles, preparaciones cosmeticas o dermatologicas que contienen los mismos y su uso para el control y la profilaxis de pigmentacion indeseada de la piel.
MX362488B (es) Composiciones y metodos para tratar la perdida del cabello y retrasar el envejecimiento de la piel.
MX342947B (es) Tratamiento de diabetes tipo 2.
MX343517B (es) 2,4 pirimidinadiaminas sustituidas para su uso en lupus discoide.
ATE538799T1 (de) Zusammensetzungen zur behandlung von haarverlust
WO2019040105A3 (en) COMPOUNDS, SALTS THEREOF AND METHODS FOR THE TREATMENT OF DISEASES
SG194410A1 (en) Skin treatments containing carboxylic acid-substituted idebenone derivatives and methods of preparation and use thereof
MX2009012714A (es) Nuevas 4-heteroail-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.
MX2009012712A (es) Nuevas 4-fenil-imidazol-2-tionas como inhibidores de la tirosinasa, su procedimiento de preparacion y su uso en medicina humana asi como en cosmetica.
MX2019011951A (es) Secretoma bacteriano para usarse en el tratamiento contra lesiones cutaneas.
MY189383A (en) Soyasaponin-containing composition for skin whitening
MX2012006217A (es) Derivados de peroxido nuevos, su proceso de preparacion y su uso en medicina humana y en cosmeticos para el tratamiento o prevencion de acne.
WO2011157610A3 (en) Use of novel amino acid derivatives as agents for treating human perspiration, and compositions containing them
WO2010129670A3 (en) Method for modulating angiogenesis using fibromodulin
EP3549638A3 (en) Pharmaceutical composition for use in treating an age-associated condition
MX2017011229A (es) Difluoro compuestos de gema como agentes de despigmentacion o de aclaramiento.

Legal Events

Date Code Title Description
FG Grant or registration